Khansa ya prostate ndi matenda amene makamaka amakhudza amuna, ndipo chiopsezo chake chimawonjezeka ndi ukalamba.
Kaŵirikaŵiri matendawa amapezeka mwa amuna a zaka zoposa 65.
Zina mwa zinthu zimene zingawonjezere chiopsezo cha kukhala ndi khansa ya prostate ndi izi:
1. M'badwo: Chiopsezo cha kansa ya prostate chimawonjezeka ndi msinkhu, ndipo milandu yambiri imachitika mwa amuna a zaka zoposa 65.
2. Mbiri ya m'banja: Amuna amene ali ndi mbiri ya m'banja ya khansa ya prostate, makamaka atate kapena mchimwene amene ali ndi matendawa, ali ndi chiopsezo chachikulu cha kukhala ndi khansa ya prostate.
3. Mtundu: Amuna a ku Africa a ku America ali ndi chiopsezo chachikulu cha kukhala ndi kansa ya prostate ndipo amakhala ndi chiopsezo chochuluka chopezeka ali wamng'ono ndi kukhala ndi mitundu yoopsa kwambiri ya nthendayo.
4. Chibadwa: Kusintha kwa majini ena, monga a majini a BRCA1 ndi BRCA2, kungawonjezere chiopsezo cha kansa ya prostate.
5. Kudya: Kudya nyama yofiira ndi mkaka wonenepa kwambiri kungawonjezere chiopsezo cha kansa ya prostate, pamene kudya zipatso ndi ndiwo zamasamba zochuluka kungachepetse chiopsezocho.
6. Kunenepa kwambiri: Kunenepa kwambiri kapena kunenepa kwambiri kungawonjezere chiopsezo cha kansa ya prostate, limodzinso ndi kuthekera kwa kansa kukhala yoopsa kwambiri.
7. Mkhalidwe wa moyo: Mkhalidwe winawake wa moyo, monga kusuta fodya ndi kusachita maseŵera olimbitsa thupi, ungawonjezere chiopsezo cha kukhala ndi kansa ya prostate.
Nkofunika kudziŵa kuti ngakhale kuti zinthu zimenezi zingawonjezere chiopsezo cha kukhala ndi kansa ya prostate, si amuna onse amene ali ndi zinthu zimenezi zimene amavutika ndi nthendayi, ndipo amuna ena amene alibe zinthu zina zodziŵika za chiopsezo angakhalebe ndi kansa ya prostate.
Kuyesedwa nthaŵi zonse ndi kukambitsirana nkhaŵa zilizonse ndi dokotala kungathandize kuzindikira khansa ya prostate msanga, pamene imatha kuchiritsidwa.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.
Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.
Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.
Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.
McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.
Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.
Chodzikanira: zachipatala
Webusaitiyi imaperekedwa kaamba ka zolinga za maphunziro ndi chidziŵitso zokha ndipo si kupereka uphungu wa zachipatala kapena mautumiki a akatswiri.
Chonde dziŵani kuti ma neural net amene amapanga mayankho a mafunso, ndi osayenerera makamaka pankhani ya manambala. Mwachitsanzo, chiŵerengero cha anthu odwala matenda enaake.
Nthawi zonse funsani upangiri wa dokotala wanu kapena wothandizira wina waluso pankhani ya matenda. Musanyalanyaze upangiri wa zamankhwala kapena kuchedwetsa kufunafuna chifukwa cha china chake chomwe mwawerenga patsamba lino. Ngati mukuganiza kuti mungakhale ndi vuto ladzidzidzi, itanani 911 kapena pitani ku chipinda chadzidzidzi chapafupi nthawi yomweyo. Palibe ubale wa dokotala ndi wodwala womwe umapangidwa ndi tsamba ili kapena kugwiritsa ntchito kwake. Neither BioMedLib kapena antchito ake, kapena aliyense wothandizira patsamba lino, amapanga ziwonetsero zilizonse, zowonetsera kapena zomveka, zokhudzana ndi chidziwitso choperekedwa pano kapena kugwiritsa ntchito kwake.
Chodzikanira: ufulu wolemba
Lamulo la Digital Millennium Copyright Act la 1998, 17 U.S.C. § 512 (the DMCA) limapereka njira yothandizira eni ake omwe amakhulupirira kuti zinthu zomwe zikuwonekera pa intaneti zimaphwanya ufulu wawo pansi pa lamulo la copyright la US.
Zidziwitso ziyenera kutumizidwa polemba kudzera pa imelo (onani gawo la "Contact" pa adilesi ya imelo).
DMCA imafuna kuti chidziwitso chanu cha kuphwanya ufulu waumwini chiphatikizepo chidziwitso chotsatirachi: (1) kufotokoza kwa ntchito yotetezedwa ndi ufulu waumwini yomwe ndi nkhani ya kuphwanya ufulu waumwini; (2) kufotokoza kwa zomwe zikunenedwa kuti zikuphwanya ufulu waumwini ndi chidziwitso chokwanira kutilola kupeza zomwe zili; (3) zidziwitso zolumikizirana nanu, kuphatikiza adilesi yanu, nambala yafoni ndi adilesi ya imelo; (4) mawu anu oti muli ndi chikhulupiriro chabwino kuti zomwe zili m'njira yomwe akudandaula sizinaloledwe ndi mwiniwake wa ufulu waumwini, kapena wothandizila wake, kapena chifukwa cha lamulo lililonse;
(5) chikalata chanu, chosainidwa pansi pa chilango cha umboni wabodza, chakuti chidziŵitso chimene chili m'chidziŵitsocho n'cholondola ndipo kuti muli ndi ulamuliro wokakamiza kukhazikitsa ufulu waumwini umene akunena kuti waphwanyidwa;
ndi (6) siginecha yakuthupi kapena yamagetsi ya mwiniwake wa ufulu waumwini kapena munthu wololedwa kuchitapo kanthu m'dzina la mwiniwake wa ufulu waumwini.
Chonde titumizireni imelo ndi funso / lingaliro lililonse.
Who gets prostate cancer?
Prostate cancer is a disease that primarily affects men, with the risk increasing with age.
It is most commonly diagnosed in men over the age of 65.
Some factors that may increase the risk of developing prostate cancer include:
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.
3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.
4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.
5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.
6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.
7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.
It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.
Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Pafupifupi
BioMedLib imagwiritsa ntchito makompyuta othandizira (ma algorithms ophunzirira makina) kuti apange mafunso ndi mayankho awiri.
Timayamba ndi zofalitsa za mankhwala a zamoyo zokwana 35 miliyoni za PubMed/Medline. Komanso, masamba a webusaiti ya RefinedWeb.
